Testicular cancer:

- Accounts for 1% of all cancers in men.
- Most common solid malignancy in males aged 15-35.
- Highly curable, with a 5-year survival rate over 95%.

### Types of Testicular Cancer

1. **Germ Cell Tumours (GCTs)**: 95% of cases
   - Pure seminoma
   - Non-seminomatous germ cell tumours (NSGCTs): teratomas, embryonal carcinomas, choriocarcinomas, yolk sac tumours.

2. **Non-Germ Cell Tumours (NGCTs)**: Includes Leydig and Sertoli cell tumours.

### Diagnosis

- Affects men aged 15-49, incidence ~7/100,000.
  
#### Common Symptoms

- Painless lump/swelling in the testicle
- Heaviness in the scrotum
- Testicular pain
- Gynaecomastia
- Metastatic symptoms:
  - Back pain (seminomas to para-aortic nodes)
  - Cough/dyspnoea (teratomas to lungs)
  - Oedema in lower extremities (vena cava obstruction)
  - Pathological neck lymph nodes (left supraclavicular)

#### Differential Diagnosis

- Conditions: epididymo-orchitis, torsion, hydrocele, haematocele, cysts, infections, lymphoma.

#### Risk Factors

- Cryptorchidism
- Family history
- HIV infection
- Male infertility
- Previous testicular cancer
- Infantile hernia
- Klinefelterâ€™s syndrome
- Low birthweight
- Young parental age
- Multiparity/breech delivery
- Tall stature
- Testicular microlithiasis

### Investigations

- Tumour marker assays: hCG, AFP, LDH
- Liver and creatinine tests
- Bilateral testicular ultrasound
- Chest X-ray
- CT scan (abdomen, lung metastases)
- Brain MRI (if elevated hCG or multiple lung metastases)
- Histological assessment via orchiectomy biopsy.

### Staging (Royal Marsden)

- **Stage I**: Local tumour, no extension through tunica albuginea.
  - IM: Persistently raised tumour markers.
  
- **Stage II**: Involvement of infradiaphragmatic lymph nodes.
  - IIA: Diameter < 2 cm
  - IIB: Diameter 2-5 cm
  - IIC: Diameter 5-10 cm
  - IID: Diameter > 10 cm

- **Stage III**: Involvement of supradiaphragmatic/infradiaphragmatic nodes.
  - IIIA: Diameter < 2 cm
  - IIIB: Diameter 2-5 cm
  - IIIC: Diameter 5-10 cm
  - M+/N+: Mediastinal/neck lymph nodes.

- **Stage IV**: Extralymphatic metastases.
  - IVA: Diameter < 2 cm
  - IVB: Diameter 2-5 cm
  - IVC: Diameter 5-10 cm
  - Lung metastases (L1, L2, L3)
  - H+: Liver involvement.

### Management (Prescribing)

- **Surgery:** Standard treatment (radical orchidectomy).
- **Stage I Seminoma:** 
  - Surveillance
  - Single-dose adjuvant carboplatin
  - Adjuvant radiotherapy

- **Metastatic Disease:** 
  - Chemotherapy/radiotherapy post-orchidectomy.
  
- **Stage IIA Seminoma:** Chemotherapy + radiotherapy.
- **Stage IIC/D:** Chemotherapy only.
- **Stage III/IV:** Cisplatin-based chemotherapy (guideline-driven).

### Management (Non-Prescribing)

- Radical orchidectomy as most effective treatment.
- Testicular prosthesis and sperm storage offered as appropriate.
- Stage I NSGCTs: Inguinal orchidectomy + adjuvant BEP chemotherapy (for high-risk patients).
- Monitor for carcinoma in situ (CIS) in contralateral testis, treat with low-dose radiotherapy or unilateral orchidectomy. 

### References

- [NHS](https://www.nhs.uk/conditions/testicular-cancer/)
- [American Cancer Society](https://www.cancer.org/cancer/testicular-cancer/treating.html)
- [UpToDate](https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-staging-of-testicular-germ-cell-tumors?search=testicular%20cancer&source=search_result&selectedTitle=1~127&usage_type=default&display_rank=1#H1)
- [Cancer Research UK](https://www.cancerresearchuk.org/about-cancer/testicular-cancer/about)
- [Patient.info](https://patient.info/doctor/testicular-cancer-pro)